Skip to content

Utility of Ultrasound Assessment of the Inferior Vena Cava in Patients With Sepsis and Dehydration

Randomized Controlled Trial of Inferior Vena Cava Ultrasonography in the Management and Disposition of Pediatric Patients Undergoing Evaluation for Sepsis and Dehydration

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02568189
Enrollment
112
Registered
2015-10-05
Start date
2015-10-01
Completion date
2016-12-31
Last updated
2024-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dehydration, Gastroenteritis, Sepsis

Keywords

Sepsis, Gastroenteritis, Dehydration, Ultrasound, Ultrasonography, Inferior Vena Cava

Brief summary

Conduct a randomized, controlled trial looking at how the use of ultrasound analyzing the inferior vena cava impacts the management and outcomes of pediatric emergency department patients undergoing evaluation and treatment of sepsis and gastroenteritis associated dehydration.

Detailed description

Ultrasound is a widely accepted and highly useful clinical tool. It carries the additional advantage of being rapid, painless and non-radiating. It has long been used to assess cardiac output and vascular pathologies. More recently emergency and trauma clinicians have been using it to assess hydration status, shock/sepsis states and fluid responsiveness. Using sonography to look at the inferior vena cava gives clinician a rapid view of vascular collapsibility that has been previously demonstrated to correlate with mean arterial pressure (MAP) and central venous pressure (CVP). Previously, Jones et. al. completed an randomized controlled trial (RCT) in adults greater than age 17 evaluating the goal directed utility of early versus delayed inferior vena cava sonography for patients presenting with non traumatic hypotension to the emergency department. This study found improved outcomes and more accuracy in diagnostic etiology in those undergoing immediate IVC imaging. The study conducts a randomized controlled trial of IVC Ultrasonography in pediatric patients 0-21 year of age. Patients admitted to the Emergency Department and triggering triage STOP SEPSIS ALERT (based on triage vital signs and chief complaint), vomiting requiring zofran or diarrhea with concern for dehydration/hypovolemia, the treating physician believes would benefit from intravenous fluids, will be eligible for inclusion into this study. The treating physician refers to one of the Pediatric Emergency Medicine attendings or fellows, listed as co-investigators. Only if and when a patient or parent expresses interest in participating in the study, the attending or fellow caring for the patient will determine if the patient is eligible. If the patient is eligible, and has no criteria that would exclude them from the study, written informed consent will be obtained from the guardian and assent will be obtained in children \> 7 years old. The patient will be enrolled in the study and randomized to either the immediate ultrasonography group (Ultrasound (US) of the Inferior Vena Cava (IVC) first before the clinician fully assesses the patient and places rehydration orders) or the control group (US at 15 minutes into the assessment and management of the patient). The goal will be to assess how the use of ultrasound impacts clinical management and outcomes in patients presenting to the pediatric emergency department with sepsis and dehydration.

Interventions

DEVICESonoSite Maxx Series Ultrasound System

Ultrasound imaging is a non-radiating, non invasive modality to assess many areas of the body including vascular fluid status. By placing the probe on the abdomen and looking at the inferior vena cava the clinician can assess a patient's degree of dehydration. We are evaluating the utility of this diagnostic intervention within the clinical management of patients in the pediatric emergency department.

Sponsors

Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 21 Years
Healthy volunteers
No

Inclusion criteria

* Trigger triage STOP SEPSIS ALERT (based on triage vital signs and chief complaint) * Present with vomiting requiring Zofran * Present with diarrhea with concern for dehydration/hypovolemia

Exclusion criteria

* Unstable patients with life-threatening injuries who require ongoing resuscitation * Patient undergoing traumatic resuscitation

Design outcomes

Primary

MeasureTime frameDescription
Type of Re-hydrationDay 1Type of re-hydration: oral vs. intravenous at the time of disposition from the Emergency Department (ED)
Vascular Access PointDay 1For sepsis arm, Secured second vascular access point- type (Interosseous (IO), second Intravenous (IV), central venous (CV) access) within 15 min of physician evaluation
Antibiotic Use60 minutesFor sepsis arm, antibiotic given within 60 min
Normal Saline Bolus60 minutesFor sepsis arm, 60 ml/kg Normal Saline bolus administered within 60 minutes

Secondary

MeasureTime frameDescription
30 Day Mortality30 daysAssessed any time after 30 days from emergency department registration date.
Disposition StatusDay 1Pediatric Intensive Care Unit (PICU), Floor, Discharge
Source of SepsisDay 1For sepsis arm, during emergency department or hospital visit
Left Ventricular FunctionDay 1For sepsis arm, during emergency department visit
Length of ED Stay (From Sepsis Alert to Admission/Discharge Order Entry)Time between emergency department registration and disposition (admit, transfer or discharge)
Return ED Visit for Same Illness Within 48 Hours48 hoursAt greater than 48 hours post emergency department disposition
Survival to Hospital Discharge30 daysFor sepsis arm, at time of emergency department or hospital discharge

Countries

United States

Participant flow

Recruitment details

Study Halted when Misclassification of Study Outcome Discovered (Different IVC Collapse criteria on IVC Ultrasound)

Pre-assignment details

112 participants and enrolled. 6 participants with inferior vena cava not visualized on ultrasound. These participants were not randomized.

Participants by arm

ArmCount
Sepsis 1
Sepsis patients receiving SonoSite Maxx Series Ultrasound System ultrasound prior to clinical orders including medication and fluid orders being placed by the treating physician SonoSite Maxx Series Ultrasound System: Ultrasound imaging is a non-radiating, non invasive modality to assess many areas of the body including vascular fluid status. By placing the probe on the abdomen and looking at the inferior vena cava the clinician can assess a patient's degree of dehydration. We are evaluating the utility of this diagnostic intervention within the clinical management of patients in the pediatric emergency department.
0
Sepsis 2
Sepsis patients having SonoSite Maxx Series Ultrasound System ultrasound performed after clinical orders have been placed by the treating physician SonoSite Maxx Series Ultrasound System: Ultrasound imaging is a non-radiating, non invasive modality to assess many areas of the body including vascular fluid status. By placing the probe on the abdomen and looking at the inferior vena cava the clinician can assess a patient's degree of dehydration. We are evaluating the utility of this diagnostic intervention within the clinical management of patients in the pediatric emergency department.
0
Gastroenteritis 1
Patients with gastroenteritis receiving SonoSite Maxx Series Ultrasound System ultrasound prior to having orders placed by treating physician SonoSite Maxx Series Ultrasound System: Ultrasound imaging is a non-radiating, non invasive modality to assess many areas of the body including vascular fluid status. By placing the probe on the abdomen and looking at the inferior vena cava the clinician can assess a patient's degree of dehydration. We are evaluating the utility of this diagnostic intervention within the clinical management of patients in the pediatric emergency department.
52
Gastroenteritis 2
Patients with gastroenteritis having SonoSite Maxx Series Ultrasound System ultrasound after initial clinical orders are placed by treating physician SonoSite Maxx Series Ultrasound System: Ultrasound imaging is a non-radiating, non invasive modality to assess many areas of the body including vascular fluid status. By placing the probe on the abdomen and looking at the inferior vena cava the clinician can assess a patient's degree of dehydration. We are evaluating the utility of this diagnostic intervention within the clinical management of patients in the pediatric emergency department.
54
Total106

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyProtocol Violation001918

Baseline characteristics

CharacteristicGastroenteritis 1Gastroenteritis 2Total
Age, Continuous6.93 years
STANDARD_DEVIATION 6.1
7.54 years
STANDARD_DEVIATION 6.31
7.2 years
STANDARD_DEVIATION 6.2
Inferior Vena Cava Status
IVC Collapse
39 Participants36 Participants75 Participants
Inferior Vena Cava Status
No IVC Collapse
11 Participants17 Participants28 Participants
Inferior Vena Cava Status
Not Visualized
2 Participants1 Participants3 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
27 Participants26 Participants53 Participants
Sex: Female, Male
Male
25 Participants28 Participants53 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 00 / 520 / 54
other
Total, other adverse events
0 / 00 / 00 / 520 / 54
serious
Total, serious adverse events
0 / 00 / 00 / 520 / 54

Outcome results

Primary

Antibiotic Use

For sepsis arm, antibiotic given within 60 min

Time frame: 60 minutes

Population: Outcome measure for sepsis arms

Primary

Normal Saline Bolus

For sepsis arm, 60 ml/kg Normal Saline bolus administered within 60 minutes

Time frame: 60 minutes

Population: Outcome measure for sepsis arms

Primary

Type of Re-hydration

Type of re-hydration: oral vs. intravenous at the time of disposition from the Emergency Department (ED)

Time frame: Day 1

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Gastroenteritis 1 (Immediate)Type of Re-hydrationOral Rehydration38 Participants
Gastroenteritis 1 (Immediate)Type of Re-hydrationIV Rehydration14 Participants
Gastroenteritis 2 (Delayed)Type of Re-hydrationOral Rehydration45 Participants
Gastroenteritis 2 (Delayed)Type of Re-hydrationIV Rehydration9 Participants
Primary

Vascular Access Point

For sepsis arm, Secured second vascular access point- type (Interosseous (IO), second Intravenous (IV), central venous (CV) access) within 15 min of physician evaluation

Time frame: Day 1

Population: Outcome measure for sepsis arms

Secondary

30 Day Mortality

Assessed any time after 30 days from emergency department registration date.

Time frame: 30 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Gastroenteritis 1 (Immediate)30 Day Mortality0 Participants
Gastroenteritis 2 (Delayed)30 Day Mortality0 Participants
Secondary

Disposition Status

Pediatric Intensive Care Unit (PICU), Floor, Discharge

Time frame: Day 1

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Gastroenteritis 1 (Immediate)Disposition StatusFloor3 Participants
Gastroenteritis 1 (Immediate)Disposition StatusDischarge49 Participants
Gastroenteritis 1 (Immediate)Disposition StatusPICU0 Participants
Gastroenteritis 2 (Delayed)Disposition StatusFloor2 Participants
Gastroenteritis 2 (Delayed)Disposition StatusDischarge52 Participants
Gastroenteritis 2 (Delayed)Disposition StatusPICU0 Participants
Secondary

Left Ventricular Function

For sepsis arm, during emergency department visit

Time frame: Day 1

Population: Outcome measure for sepsis arms

Secondary

Length of ED Stay (From Sepsis Alert to Admission/Discharge Order Entry)

Time frame: Time between emergency department registration and disposition (admit, transfer or discharge)

Population: No participants enrolled in Sepsis arms

ArmMeasureValue (MEAN)Dispersion
Gastroenteritis 1Length of ED Stay (From Sepsis Alert to Admission/Discharge Order Entry)200 minutesStandard Deviation 121
Gastroenteritis 2Length of ED Stay (From Sepsis Alert to Admission/Discharge Order Entry)177 minutesStandard Deviation 106
Secondary

Return ED Visit for Same Illness Within 48 Hours

At greater than 48 hours post emergency department disposition

Time frame: 48 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Gastroenteritis 1 (Immediate)Return ED Visit for Same Illness Within 48 Hours0 Participants
Gastroenteritis 2 (Delayed)Return ED Visit for Same Illness Within 48 Hours0 Participants
Secondary

Source of Sepsis

For sepsis arm, during emergency department or hospital visit

Time frame: Day 1

Population: Outcome measure for sepsis arms

Secondary

Survival to Hospital Discharge

For sepsis arm, at time of emergency department or hospital discharge

Time frame: 30 days

Population: Outcome measure for sepsis arms

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026